Affordable Access

deepdyve-link
Publisher Website

15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma.

Authors
  • Byrne, Keelan1
  • Siva, Shankar2
  • Chait, Lori3
  • Callahan, Jason4
  • Bressel, Mathias5
  • Seel, Matthew6
  • MacManus, Michael P7
  • Hicks, Rodney J8
  • 1 Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. , (Australia)
  • 2 Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia [email protected] , (Australia)
  • 3 University of Notre Dame, Sydney, Australia. , (Australia)
  • 4 Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia. , (Australia)
  • 5 Department of Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia; and. , (Australia)
  • 6 Department of Radiation Oncology, Waikato Regional Cancer Centre, Hamilton, New Zealand. , (New Zealand)
  • 7 Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. , (Australia)
  • 8 Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia. , (Australia)
Type
Published Article
Publication Date
Sep 01, 2015
Volume
56
Issue
9
Pages
1328–1333
Identifiers
DOI: 10.2967/jnumed.115.158261
PMID: 26159592
Source
Medline
Keywords
License
Unknown

Abstract

(18)F-FDG PET imaging had a high impact on restaging after definitive treatment in patients with MCC. Metabolic response was significantly associated with overall survival. (18)F-FDG PET may play an important role in ongoing post-treatment management of MCC.

Report this publication

Statistics

Seen <100 times